Termin buchen Anrufen Kontakt
Eiche auf weiter Wiese – Sinnbild für Souveränität und Beständigkeit
Making visible what hides in dense tissue.
Breast MRI · Munich

Breast MRI (MR mammography)

The most sensitive method of breast imaging. Calmly and with time.

Especially in dense breast tissue, mammography reaches its limits – dense tissue and tumour both appear white. Contrast-enhanced MRI is the most sensitive imaging method of the breast and reveals even small changes – without X-rays, without compression.

Our promise
When breast MRI makes sense

Two good reasons to look closer

If you have symptoms or notice changes

A newly palpable lump, discharge or blood from the nipple, skin changes or a new change in shape – please do not delay diagnostic work-up. Contact your gynaecologist or come to us directly. MRI is considered the most sensitive method of breast imaging.⁸

With elevated risk

In cases of familial or genetic predisposition (e.g. BRCA1/2), contrast-enhanced breast MRI is an internationally recommended part of early detection.¹

To clarify unclear findings

When mammography or ultrasound leave questions open, MRI provides clarity – often the decisive step before further measures such as a biopsy are considered.

The examination

One of the gentlest procedures for the breast

MR mammography with dynamic contrast administration is one examination – and one of the safest and gentlest examination procedures for the breast: without X-rays, without compression. Via the perfusion behaviour of the tissue it achieves the highest sensitivity of all breast imaging methods.

Strong in dense tissue

Dense glandular tissue appears white on X-ray – just like a tumour. MRI is independent of tissue density and shows changes where mammography reaches its limits.

Contrast dynamics & diffusion

Tumour tissue forms additional vessels and takes up contrast agent in a characteristic way – the dynamic measurement makes this behaviour visible. Complemented by diffusion-weighted imaging (DWI with ADC map)², which captures differences in tissue density, together they form the basis of the high sensitivity.

No X-rays, no compression

MRI works with magnetic fields instead of ionising radiation – and does without compressing the breast.

Structured reporting

Every examination is assessed in a structured way according to the international standard (BI-RADS) – with clear classification and a comprehensible recommendation for the next steps.

Implants reliably assessed

With silicone-selective special sequences, implants can be assessed specifically: MRI is regarded as the gold standard for detecting a rupture – including the “silent”, inward-facing kind – as well as silicone that has escaped into the tissue and accompanying foreign-body reactions.³

Dr. Dr. Georg-Friedemann Rust im Gespräch mit einer Patientin
Your doctor
The fear of the finding is often greater than the finding itself.
Dr. Dr. Georg-Friedemann Rust
Specialist in Radiology & Neuroradiology
How it works

Three steps to certainty

Book an appointment

Conveniently online or by phone – you receive an appointment promptly through our friendly reception.

The examination

The scan is performed in a modern, open and short MRI – comfortable even with claustrophobia. The contrast agent is given via an arm vein.

Findings & discussion

You receive a detailed report and a personal discussion of the next steps.

Your doctor

Personally there for you

Dr. Dr. Georg-Friedemann Rust – Facharzt für Radiologie und Neuroradiologie

Dr. Dr. Georg-Friedemann Rust

Specialist in Radiology & Neuroradiology

Physicist and radiologist – combining medical and technical expertise for precise imaging and personal care.

What our patients say

Trust that grows from experience

★★★★★  87 × 5-star reviews on Google

Google
★★★★★
“A doctor and physicist who combines the highest professional competence with a very pleasant manner – the patient is at the centre, and the findings are explained in an understandable way.”
Thomas S. · Google
Google
★★★★★
“Competent, attentive, thorough. He helps where other doctors fail.”
Jonas S. · Google
Google
★★★★★
“He conveyed the findings factually, calmly and clearly. A welcome angel after days of panic over an orthopaedist’s preliminary finding.”
Verifizierter Patient · Selbstzahler · Google
Google
★★★★★
“I have been coming here for years – always reliable, friendly and professional. The team takes its time.”
Firat S. · Google
Google
★★★★★
“No waiting time, short-notice appointments, very competent. The best radiology practice in Munich!”
Svetlana M. · Google

Gain clarity

Arrange your appointment – online in a few steps or by phone.

Breast cancer is the most common cancer in women: about one in eight women develops it in her lifetime, and around 75,000 new cases and about 18,500 deaths are registered each year.⁴ Decisive for the prognosis is how early a change is detected: below one centimetre in size it is considered a local process with a very good outlook.⁵ This is exactly where contrast-enhanced MRI is strong – it is the most sensitive imaging method of the breast and, through the perfusion behaviour, makes even small tumours visible that remain hidden in mammography in dense tissue.⁶ For a proven high risk it is internationally recommended as a preventive method.¹ Important: statutory mammography remains the established screening method with a proven reduction in mortality – MRI complements it where its sensitivity makes the decisive difference. For context: as feared as breast cancer is, cardiovascular disease is the most common cause of death in women and, at a good third of all deaths, claims more lives than all cancers combined.⁷ Whether MR mammography makes sense in your case is something we clarify together and in coordination with your gynaecologist.

Studies show how large the difference is: in very dense breast tissue, X-ray mammography detects only about half of all tumours (48 %), whereas in fatty tissue it detects almost all (98 %).⁹ In the German EVA trial in women at increased familial risk, MRI found 93 % of cancers, mammography 33 % and ultrasound 37 %.¹⁰ In the Dutch DENSE trial, supplemental MRI in very dense breasts halved the number of cancers occurring between two screening rounds (2.5 instead of 5.0 per 1,000 examinations).¹¹ The flip side of this high sensitivity: MRI also finds more benign changes that need further work-up – which is why it belongs in experienced hands.

References
  1. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group. Eur J Cancer 2010;46(8):1296–1316.
  2. Baltzer P, Mann RM, Iima M, et al. Diffusion-weighted imaging of the breast – a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol 2020;30(3):1436–1450.
  3. Fischer U, Baum F, Luftner-Nagel S. Komplikationen von Implantaten der weiblichen Brust in der MRT. Radiologie up2date 2021;21(1):59–77.
  4. Robert Koch-Institut, Zentrum für Krebsregisterdaten (ZfKD) & Deutsche Krebsregister e. V. Krebs in Deutschland für 2021–2023, 2025.
  5. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63(1):181–187.
  6. Comstock CE, Gatsonis C, Newstead GM, et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts (ECOG-ACRIN EA1141). JAMA 2020;323(8):746–756.
  7. Statistisches Bundesamt (Destatis), Todesursachenstatistik 2024 – Herz-Kreislauf-Erkrankungen als häufigste Todesursache bei Frauen (35,4 % der weiblichen Sterbefälle).
  8. Leitlinienprogramm Onkologie (DKG, DKH, AWMF): S3-Leitlinie Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms, AWMF-Reg.-Nr. 032-045OL. awmf.org
  9. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225(1):165–175.
  10. Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010;28(9):1450–1457.
  11. Bakker MF, de Lange SV, Pijnappel RM, et al. Supplemental MRI screening for women with extremely dense breast tissue (DENSE). N Engl J Med 2019;381(22):2091–2102.
Book Call Contact
Farbstimmung
Wählen Sie die Ansicht, die Ihnen am angenehmsten ist.